Ivermectin, Mebendazole, and Fenbendazole are effective treatments sav… — Fact Check: Inaccurate

What was claimed

Ivermectin, Mebendazole, and Fenbendazole are effective treatments saving the lives of terminal cancer patients where mainstream medicine has given up, and criticism of them is fraudulent

Our verdict

Inaccurate

Laboratory and animal studies show anticancer activity, but major authorities like the American Cancer Society state ivermectin is not approved for cancer and has no proven benefit against cancer, and no clinical guidelines recommend it as a cancer treatment. UCLA Health similarly notes that no clinical trials have shown ivermectin is safe or effective for treating cancer in people. <cite index="24-1,24-2">Ivermectin is not approved to treat any cancer in people or in animals. No clinical guidelines recommend it as a cancer treatment.</cite> <cite index="2-6">Ivermectin is not FDA-approved for the treatment of cancer in humans.</cite> <cite index="2-15">Fenbendazole is not FDA-approved for human use.</cite>.

All 3 AI systems agree9 sources citedChecked Jun 29, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

Criticism of these drugs for cancer treatment is fraudulent

Incorrect93%

All 2 AIs agree

These drugs have proven clinical efficacy in terminal cancer patients

Incorrect95%

1 AI checked

Ivermectin, Mebendazole, and Fenbendazole are effective treatments saving the lives of terminal cancer patients where mainstream medicine has given up

Incorrect95%

6 of 8 AIs agree·Perplexity: Misleading, Perplexity: Can’t verify

These drugs are approved treatments for cancer

Incorrect99%

1 AI checked

Mainstream medicine has given up on these patients

Misleading85%

1 AI checked

Verified against 9 sources

pubmed.ncbi.nlm.nih.gov

Detailed Analysis

Current evidence does not show that ivermectin, mebendazole, or fenbendazole are proven life‑saving treatments for terminal cancer patients, and major oncology and public health organizations explicitly state that their effectiveness against cancer in humans is unproven. The claim that criticism of these drugs is fraudulent misrepresents the scientific consensus and dismisses legitimate, evidence‑based concerns about safety and efficacy.

Why this verdict

Current evidence does not show that ivermectin, mebendazole, or fenbendazole are proven life‑saving treatments for terminal cancer patients, and major oncology and public health organizations explicitly state that their effectiveness against cancer in humans is unproven.
The claim that criticism of these drugs is fraudulent misrepresents the scientific consensus and dismisses legitimate, evidence‑based concerns about safety and efficacy.

Claims checked

Fenbendazole is an effective treatment saving the lives of terminal cancer patients where mainstream medicine has given up.

Incorrect95%

Fenbendazole is approved only for veterinary use, and UCLA Health notes that no clinical trials have shown it is safe or effective for treating cancer in people.[6] Evidence consists primarily of in vitro data and a very small case series, and the Anticancer Fund stresses that for ivermectin and fenbendazole, rigorous clinical trials in humans are missing and scientific evidence for cancer treatment is very limited.[4] [5]

This claim may mislead readers without added context.

Ivermectin is an effective treatment saving the lives of terminal cancer patients where mainstream medicine has given up.

Incorrect96%

This claim may mislead readers without added context.

Ivermectin, mebendazole, and fenbendazole are effective treatments for cancer in humans.

Incorrect96%

While these antiparasitic drugs show antitumor effects in cell and animal models, multiple authoritative sources state that human evidence is limited, early, and insufficient to conclude they are effective cancer treatments.[4] [5] The American Cancer Society explicitly states that at this time, no scientific evidence supports prescribing ivermectin off label to people with cancer.[7]

This claim may mislead readers without added context.

What other AI think

The claim makes multiple false and misleading assertions. These drugs lack FDA approval for cancer treatment, have no proven clinical efficacy in humans, and are not recommended by oncologists or cancer organizations. Characterizing legitimate scientific criticism as "fraudulent" is itself misleading.

Why this verdict

The claim makes multiple false and misleading assertions.
These drugs lack FDA approval for cancer treatment, have no proven clinical efficacy in humans, and are not recommended by oncologists or cancer organizations.
Characterizing legitimate scientific criticism as "fraudulent" is itself misleading.

Claims checked

Ivermectin, Mebendazole, and Fenbendazole are effective treatments saving the lives of terminal cancer patients

Incorrect95%

<cite index="20-1">There is no high-quality clinical evidence showing that ivermectin improves survival or shrinks tumors in people with cancer.</cite> <cite index="1-6">Despite promising laboratory and anecdotal clinical results, robust randomized controlled trials are lacking, and regulatory approval for cancer indications remains limited.</cite> <cite index="5-9">In a phase 2a clinical study, individualized dose adjusted mebendazole was safe and well tolerated in patients with advanced cancer but all patients experienced rapid progressive disease.</cite>

This claim may mislead readers without added context.

Criticism of these drugs for cancer treatment is fraudulent

Incorrect95%

Criticism comes from legitimate medical sources. <cite index="18-6">Gynecologic cancer specialists do not recommend and strongly caution the use of ivermectin in the treatment of gynecologic cancers.</cite> <cite index="24-16">No scientific evidence supports prescribing ivermectin off label to people with cancer.</cite> These are evidence-based positions, not fraud.

This claim may mislead readers without added context.

These drugs have proven clinical efficacy in terminal cancer patients

Incorrect95%

<cite index="2-9,2-12">Fenbendazole lacks regulatory approval for human use, research is predominantly preclinical and limited, and lacks large, controlled clinical trials assessing its efficacy in cancer.</cite> <cite index="17-8,17-9">The majority of publications are preclinical, meaning results show anticancer effects at the cellular level in cells or mice, completely outside the human body. There is currently no proven clinical role for ivermectin in cancer treatment.</cite>

This claim may mislead readers without added context.

The statement makes strong medical claims that contradict current evidence. High-quality human clinical trials do not show these drugs are proven, life‑saving cancer treatments, and safety concerns exist.

Why this verdict

The statement makes strong medical claims that contradict current evidence.
High-quality human clinical trials do not show these drugs are proven, life‑saving cancer treatments, and safety concerns exist.

Claims checked

Criticism of them is fraudulent

Incorrect90%

Critiques are based on the lack of rigorous human trial evidence and documented safety concerns; independent fact‑checks and medical authorities have raised legitimate scientific and safety objections rather than fraudulent motives.

This claim may mislead readers without added context.

Ivermectin, Mebendazole, and Fenbendazole are effective treatments saving the lives of terminal cancer patients where mainstream medicine has given up

Incorrect93%

There is no high‑quality, conclusive clinical trial evidence that these drugs reliably cure or save terminal cancer patients; ivermectin is not approved for cancer, mebendazole has limited early/small studies but no definitive proof, and fenbendazole lacks robust human trials and has reported harms.

This claim may mislead readers without added context.

Share this result

Try DoubleChecks